Schroder Investment Management Group Buys 366,283 Shares of Cardinal Health, Inc. $CAH

Schroder Investment Management Group increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 261.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 506,465 shares of the company’s stock after buying an additional 366,283 shares during the quarter. Schroder Investment Management Group owned 0.21% of Cardinal Health worth $85,086,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of CAH. Geode Capital Management LLC lifted its holdings in shares of Cardinal Health by 3.3% in the second quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock valued at $1,069,005,000 after purchasing an additional 205,539 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Cardinal Health by 40.0% in the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after buying an additional 1,193,983 shares in the last quarter. Norges Bank bought a new position in shares of Cardinal Health in the 2nd quarter valued at about $584,420,000. Northern Trust Corp increased its position in Cardinal Health by 3.5% during the first quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock worth $433,012,000 after buying an additional 105,154 shares during the last quarter. Finally, Wellington Management Group LLP increased its holdings in shares of Cardinal Health by 1,666.7% during the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after acquiring an additional 2,249,241 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on CAH. TD Cowen increased their target price on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 3rd. Leerink Partners boosted their target price on shares of Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a research report on Monday, November 17th. Citigroup upped their price objective on Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a research report on Friday, October 31st. Evercore ISI increased their price objective on shares of Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research note on Friday, October 31st. Finally, Argus lifted their price target on Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $206.57.

Cardinal Health Stock Performance

Shares of Cardinal Health stock opened at $212.26 on Friday. The stock has a market capitalization of $50.43 billion, a PE ratio of 32.91, a price-to-earnings-growth ratio of 1.39 and a beta of 0.72. The stock has a 50 day moving average price of $177.57 and a two-hundred day moving average price of $163.40. Cardinal Health, Inc. has a 52 week low of $114.60 and a 52 week high of $214.93.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company’s revenue for the quarter was up 22.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a $0.5107 dividend. The ex-dividend date is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s payout ratio is presently 30.77%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.